GPR35 and osteoporosis: Previous studies have indicated that GPR35 is downregulated in individuals with osteoporosis and in mouse models of the disease (Zhang et al. 2021) and that activation of GPR35 improves bone density in osteoporotic mice (Ma et al. 2023).